A human IPS cell model for gene therapy vector safety evaluation Phase 2
Funder: Medical Research CouncilDuration: January 2017 - June 2019
People
| Name | Telephone | Office | ||
|---|---|---|---|---|
|
Professor Michael Themis Professor - Gene Therapy and Genotoxicity (Principal investigator)
T: +44 (0)1895 267252
E: michael.themis@brunel.ac.uk |
+44 (0)1895 267252 | michael.themis@brunel.ac.uk | Heinz Wolff 235 |
Outputs
Themis, M. (2024) 'Analysis of HIV-1 based lentiviral vector particle composition by PacBio long-read nucleic acid sequencing'. Human Gene Therapy. ISSN: 1043-0342